News

Choosing the Right Excipient for Optimal Dosage Form Performance in Immunocompromised Patients

Read more

News

Technologies that assist in compounding

Read more

ESG

Preventing corruption and bribery

Read more

News

Enhancing Psoriasis Treatment with Advanced Compounding Solutions

Read more

News

SyrSpend® SF PH4 NEO has a new brochure!

Read more

ESG

Science-based carbon footprint targets – Part 2

Read more

News

Library: A repository for all Fagron-related scientific literature

Read more

News

Formulary: Our new scientific formulas database

Read more

News

Addressing the specific needs of Pediatric and Geriatric patients through Oral Suspensions

Read more

ESG

Build the Organization of the Future: Fagron’s Commitment to ESG and Stakeholder Engagement

Read more